Crucell N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
13 nov 2007 - 08:03
Statutaire naam
Crucell N.V.
Titel
Crucell Announces Third Quarter 2007 Results
Bericht
Total revenue and other operating income increased by 115% to €62.6 million in the third quarter compared to the same quarter last year, largely driven by increased sales of Quinvaxem™ and Inflexal® V.
Gross margin in the third quarter improved from 19.5% last year to 35.9%.
Full year guidance reiterated; total revenues and other operating income of
€220-225 million; cash break-even on ‘net cash from operating activities’.
Gerelateerde downloads
Datum laatste update: 05 februari 2025